Page last updated: 2024-12-07

n-phenethylbenzamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

n-phenethylbenzamide is a synthetic compound that has been investigated for its potential pharmacological properties. It has been shown to exhibit activity as a monoamine oxidase (MAO) inhibitor, particularly against MAO-A, which plays a role in the breakdown of neurotransmitters like serotonin and norepinephrine. Research has focused on exploring its potential therapeutic applications, including as an antidepressant and an anti-anxiety agent. Furthermore, it has been explored as a potential treatment for neurodegenerative diseases, such as Alzheimer's disease, due to its ability to modulate neurotransmitter levels and its potential neuroprotective effects.'

N-phenethylbenzamide: has antioxidant activity; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID95083
CHEMBL ID4852435
SCHEMBL ID751214
MeSH IDM000603997

Synonyms (35)

Synonym
nsc43723
nsc-43723
n-phenethyl-benzamide
benzamide, n-(2-phenylethyl)-
nsc-16618
nsc16618
3278-14-6
STK407996
n-(2-phenylethyl)benzamide
nsc 16618
AKOS000277620
FT-0658597
n-phenethylbenzamide
A821413
nsc 43723
CS-B0306
SCHEMBL751214
n-phenethyl benzamide
benzoic acid-beta-phenylethylamide
4-(dichloromethyl)pyridine hcl
W-202344
n-(2-phenethyl)benzamide
n-(2-phenylethyl)benzamide #
AC-22543
benzamide,n-(2-phenylethyl)-
benzamide, n-(2-phenylethyl)- (9ci)
DTXSID90186443
Z27761643
n-benzoyl-2-phenylethylamine
mfcd00441484
AMY2395
EN300-1087060
CS-16860
HY-32135
CHEMBL4852435
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1754175Antiinflammatory activity in mouse RAW264.7 assessed as inhibition of LPS-induced NO production preincubated for 30 mins followed by LPS stimulation measured after 24 hrs by Griess reagent based assay2021Journal of natural products, 05-28, Volume: 84, Issue:5
Tulipiferamide A, an Alkamide from
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's3 (60.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]